Loading…
CIK 0001910456 • 7 13F filings • May 15, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("lynx1-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABSCI CORPORATION | COM | $64K | 0.0% | 21,245 SH | New |
| AGIOS PHARMACEUTICALS INC | COM | $88.3M | 14.0% | 2,611,568 SH | New |
| BOLT BIOTHERAPEUTICS INC | COM NEW | $124K | 0.0% | 30,800 SH | New |
| C4 THERAPEUTICS INC | COM STK | $18.4M | 2.9%Prev: 4.1% | 6,998,902 SH | Increased-99,231 SH |
| CG ONCOLOGY INC | COM | $2.1M | 0.3% | 31,591 SH | New |
| CULLINAN THERAPEUTICS INC | COM | $127.4M | 20.1%Prev: 8.7% | 8,963,500 SH | Increased+5,747,778 SH |
| DENALI THERAPEUTICS INC | COM | $36.1M | 5.7% | 1,880,303 SH | New |
| DESIGN THERAPEUTICS INC | COM | $1.3M | 0.2%Prev: 0.1% | 119,516 SH | Increased+53,562 SH |
| ENTRADA THERAPEUTICS INC | COM | $2.7M | 0.4% | 211,689 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $151.3M | 23.9%Prev: 25.5% | 10,763,288 SH | Increased+4,319,348 SH |
| IBIO INC | COM NEW | $129K | 0.0% | 68,076 SH | New |
| IMMATICS N.V | SHS | $2.1M | 0.3% | 216,973 SH | New |
| KORRO BIO INC | COM | $17.4M | 2.8% | 1,538,296 SH | New |
| NEUPHORIA THERAPEUTICS INC | COM | $3.6M | 0.6%Prev: 0.1% | 875,328 SH | Increased+829,522 SH |
| PASSAGE BIO INC | COM NEW | $4.9M | 0.8% | 623,704 SH | New |
| PRECISION BIOSCIENCES INC | COM NEW | $5.4M | 0.9%Prev: 1.3% | 985,113 SH | Increased+219,062 SH |
| PROQR THRAPEUTICS N V | SHS EURO | $111K | 0.0% | 68,486 SH | New |
| STOKE THERAPEUTICS INC | COM | $155.1M | 24.5%Prev: 12.6% | 4,763,673 SH | Increased-528,256 SH |
| TRAWS PHARMA INC | COM NEW | $28K | 0.0% | 15,078 SH | New |
| TSCAN THERAPEUTICS INC | COM | $8.1M | 1.3%Prev: 2.6% | 8,019,148 SH | Increased+2,661,801 SH |
| VYNE THERAPEUTICS INC | COM | $973K | 0.2% | 1,628,700 SH | New |
| WEREWOLF THERAPEUTICS INC | COM | $548K | 0.1% | 657,786 SH | New |
| XENCOR INC | COM | $6.5M | 1.0% | 536,398 SH | New |
| 13F-HR/A |
| 0001910456-26-000004 |
| $865.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001085146-25-005127 | $346.2M | View |
| May 4, 2026 | Q1 2026 | 13F-HR | 0001910456-26-000002 | $632.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001892688-25-000120 | $279.2M | View |